The global biologics market is anticipated to touch USD 285,520.4 million at a 6.95% CAGR between 2018-2023, states the new Market Research Future (MRFR) report. Biologics, simply put, are made from materials that come from various living organisms such as animals, humans, and microorganisms, namely yeast or bacteria. Usually, biological products are manufactured, utilizing biotechnology methods or other advanced technologies. They are widely used for providing effective treatment for several complex diseases, including Crohn’s disease, psoriasis, and rheumatoid arthritis, which have limited options for treatment. Biologics is transforming the manner in which physicians treat common conditions that have plagued people for years. They have many potential benefits as; theoretically, they can be customized for hitting particular gene targets in the body
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1339
Numerous factors are propelling the biologics market. Such factors, as per the new Market Research Future report, include unremitting research & development activities, rising regulatory convergence, increasing government initiatives in the healthcare sector, growing demand as well as higher acceptability of innovative therapies, and the emergence of orphan drugs and personalized medicines. Additional factors propelling the growth of the biologics market include improvement in the healthcare infrastructure, rapid urbanization, increasing awareness about the efficacy and performance of biologics, and increasing prevalence of different chronic diseases.
On the contrary, stringent government regulations, higher supervision, the rise of biosimilars, pricing pressures coming from regulators, difficulty to manufacture biologics, and side effects such as breathing problems, chest pain, change in blood pressure, and gastrointestinal complications are factors that may hamper the biologics market growth during the forecast period.
Market Segmentation
The Market Research Future report offers a complete segmental analysis of the biologics market based on manufacturing, disease indication, and product.
Based on product, the global biologics market is segmented into gene therapy, growth factors, vaccines, interleukins, monoclonal antibody, and others. Of these, the monoclonal antibody segment will have the largest share in the market during the forecast period for its increasing use for enhancing the body’s immunity system.
Based on disease indication, the biologics market is segmented into diabetes, cancer, psoriasis/psoriatic arthritis, rheumatoid arthritis, and others. Of these, the cancer segment dominated the market in 2018, but rheumatoid arthritis is predicted to dominate the biologics market over the forecast period for the rapid approval of different drugs by the regulatory agencies.
Based on manufacturing, the biologics market is segmented into outsourced and in-house. Of these, the outsourced segment will have the maximum share in the market during the forecast period for the presence of several pharmaceutical companies, especially in developing countries.
Competitive Landscape
Biologics has seen increased demand over the years, due to the innovations in biologics and negligible health effects and the incidence of prevailing chronic diseases. Companies functioning in the global market are also being challenged due to companies with lower capacities and emergence of biosimilars. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period. As the market is set to register a high CAGR of 6.95% and is also anticipated to reach a US$285,520.4 million by 2023, the report highlights key areas companies need to focus on. The report suggests that the biologics market will see a healthy growth in the long run till 2023. Based on SWOT analysis and market’s analysis based on Porters’ Five Force Model presented in the market report. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period.
Regional Analysis
By region, the biologics market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa. Of these, the Americas will dominate the market during the forecast period. Various factors are propelling the growth of the biologics market in the region, such as investments in new facilities for producing drugs for clinical trials, strong economic growth of Canada and the US, and rapid adoption of manufacturing technologies. It is predicted to touch USD 129,652.7 million at a 4.31% CAGR.
The biologics market in the APAC region will grow at the fastest pace during the forecast period. Various factors are propelling the growth of the biologics market in the region, such as the changing healthcare sector, increasing geriatric populace, and the presence of different contract manufacturing organizations (CMOs) in the region. India is a major contributor in this region for its massive strides in biologics manufacturing.
Key Players
Notable players profiled in the biologics market report include GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi (France), F. Hoffman-La Roche AG (Switzerland), Novartis AG (Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca (UK), and AbbVie, Inc. (US). Key players have incorporated specific strategies to increase their market share, such as acquisitions, expansions, and new product launches.
Industry News
WuXi Biologics, a multinational organisation with leading open-access biologics networks and services, and Bayer recently announced that WuXi Biologics would take over and run Bayer's Drug Substance (DS) facility in Wuppertal. A long-term sublease deal and a relocation management contract are both planned by the firms. The total purchase value, including the sublease deal, is estimated to be about 150 million euros.
1 Report Prologue
2 Market Introduction
2.1 Introduction 15
2.2 Scope Of The Study 15
2.3 Assumptions & Limitations 15
3 Research Methodology
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 20
3.4 Market Size Estimation 21
3.5 Forecast Model 21
4 Market Dynamics
4.1 Introduction 23
4.2 Drivers 23
4.2.1 Increasing Healthcare Expenditure 23
4.2.2 Advancements In Biologics 24
4.2.3 Rising Prevalence Of Chronic And Acute Diseases 24
4.3 Restraints 24
4.3.1 Emergence Of Biosimilars 24
4.3.2 Adverse Effects Of Biologic Drugs 24
4.4 Opportunities 25
4.4.1 Strong Pipeline For Biologic Drugs 25
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis 27
5.1.1 Research & Development 27
5.1.2 Raw Material 27
5.1.3 Manufacturer 27
5.1.4 Distributor 28
5.1.5 Customer 28
5.1.6 Consumer 28
5.2 Porter’s Five Force Analysis 29
5.2.1 Threat From A New Entrant 30
5.2.2 Bargaining Power Of Buyer 30
5.2.3 Bargaining Power Of Supplier 30
5.2.4 Threat From Substitute 31
5.2.5 Rivalry 31
5.3 Investment Opportunity Analysis 32
5.3.1 Investment Risks 32
5.3.2 Market Outlook 32
5.4 Pricing Analysis 32
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/biologics-market-1339
Related reports link:-
Amyotrophic Lateral Sclerosis Market
Compression Therapy Market
Veterinary Vaccines Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
